Allergen filed suit in the U.S. District Court for the Eastern District of Texas on Thursday, claiming that Watson infringed four patents when it filed an abbreviated new drug application with the U.S. Food and Drug Administration for generic Combigan.

According to the complaint, the plaintiff received a letter from Watson on July 30 saying that it had filed...